Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
NOV Analyst Ratings
Moderate Buy
7 Buy
5 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NOV Stock 12 Month Forecast
Average Price Target
€90.75
▲(66.94% Upside)
| Highest Price Target€133.46 | Average Price Target€90.75 | Lowest Price Target€44.04 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Deutsche Bank
Reiterated
04/22/25
Kepler Capital
Reiterated
04/22/25
Goldman Sachs
Reiterated
04/22/25
J.P. Morgan
Reiterated
04/17/25
Bernstein
Reiterated
04/17/25
Jefferies
Reiterated
04/17/25
Barclays
Reiterated
04/16/25
Bank of America Securities
Reiterated
03/28/25
Morgan Stanley
€93.42→€80.07
Hold
47.30%
Upside
Reiterated
03/27/25
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK600 at Morgan StanleyMorgan Stanley analyst Thibault Boutherin lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK600.00 (from DKK700.00) while maintaining a Equalweight rating.
Berenberg Bank
€96.76→€81.41
Hold
49.76%
Upside
Reiterated
03/24/25
Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank
Stifel Nicolaus
€104.1→€93.42
Hold
71.85%
Upside
Downgraded
03/03/25
Novo Nordisk downgraded to Hold from Buy at StifelNovo Nordisk downgraded to Hold from Buy at Stifel
DZ BANK AG
―
Hold
―
Reiterated
02/06/25
DZ BANK AG Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Guggenheim
€106.1→€106.5
Buy
95.91%
Upside
Reiterated
01/17/25
Novo Nordisk price target raised to DKK 798 from DKK 795 at GuggenheimNovo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
Reiterated
04/22/25
Kepler Capital
Reiterated
04/22/25
Goldman Sachs
Reiterated
04/22/25
J.P. Morgan
Reiterated
04/17/25
Bernstein
Reiterated
04/17/25
Jefferies
Reiterated
04/17/25
Barclays
Reiterated
04/16/25
Bank of America Securities
Reiterated
03/28/25
Morgan Stanley
€93.42→€80.07
Hold
47.30%
Upside
Reiterated
03/27/25
Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK600 at Morgan StanleyMorgan Stanley analyst Thibault Boutherin lowered the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK600.00 (from DKK700.00) while maintaining a Equalweight rating.
Berenberg Bank
€96.76→€81.41
Hold
49.76%
Upside
Reiterated
03/24/25
Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank
Stifel Nicolaus
€104.1→€93.42
Hold
71.85%
Upside
Downgraded
03/03/25
Novo Nordisk downgraded to Hold from Buy at StifelNovo Nordisk downgraded to Hold from Buy at Stifel
DZ BANK AG
―
Hold
―
Reiterated
02/06/25
DZ BANK AG Sticks to Their Hold Rating for Novo Nordisk (0QIU)
Guggenheim
€106.1→€106.5
Buy
95.91%
Upside
Reiterated
01/17/25
Novo Nordisk price target raised to DKK 798 from DKK 795 at GuggenheimNovo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
Best Analysts Covering Novo Nordisk
Which Analyst Should I Follow If I Want to Buy DE:NOV and Sell After:
1 Month
xxx
Success Rate
33/56 ratings generated profit
Average Return
+1.09%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.93% of your transactions generating a profit, with an average return of +1.09% per trade.
3 Months
xxx
Success Rate
36/56 ratings generated profit
Average Return
+3.31%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +3.31% per trade.
1 Year
Success Rate
41/56 ratings generated profit
Average Return
+19.10%
reiterated a buy rating 11 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 73.21% of your transactions generating a profit, with an average return of +19.10% per trade.
2 Years
xxx
Success Rate
33/56 ratings generated profit
Average Return
+19.58%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.93% of your transactions generating a profit, with an average return of +19.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NOV Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
1
9
14
20
22
Buy
24
29
26
25
15
Hold
20
19
19
17
15
Sell
7
8
8
4
5
Strong Sell
0
0
0
0
0
total
52
65
67
66
57
Each month's total comprises the sum of three months' worth of ratings.
NOV Financial Forecast
NOV Stock Forecast FAQ
What is DE:NOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is 90.75.
What is DE:NOV’s upside potential, based on the analysts’ average price target?
Novo Nordisk has 66.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novo Nordisk a Buy, Sell or Hold?
Novo Nordisk has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 5 hold ratings and 2 sell ratings.
What is Novo Nordisk’s share price target?
The average share price target for Novo Nordisk is 90.75. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €133.46 ,and the lowest forecast is €44.04. The average share price target represents 66.94% Increase from the current price of €54.36.
The highest analyst share price target is €133.46 ,and the lowest forecast is €44.04. The average share price target represents 66.94% Increase from the current price of €54.36.
What do analysts say about Novo Nordisk?
Novo Nordisk’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Novo Nordisk?
To buy shares of DE:NOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.